3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Neoplasms
3
Stress Disorders, Post-Traumatic
1
Motor Activity
1
Mental Fatigue
1
Fatigue
1
Depression
1
Cognitive Dysfunction
1
Anxiety Disorders
1
Advanced Cancer
1
Interventions
Surveys and Questionnaires
7
Standard of Care
5
Sirolimus
5
Bevacizumab
5
temsirolimus
4
Interviews as Topic
4
Paclitaxel
3
olaparib
2
Vorinostat
2
Olanzapine
2
Magnetic Resonance Spectroscopy
2
Gemcitabine
2
Everolimus
2
Erlotinib Hydrochloride
2
Dasatinib
2
Cetuximab
2
zaleplon
1
vistusertib
1
tilsotolimod
1
pazopanib
1
olanzapine-fluoxetine combination
1
nimotuzumab
1
liposomal doxorubicin
1
capivasertib
1
apatinib
1
Videotape Recording
1
Vemurafenib
1
Valproic Acid
1
Trastuzumab
1
Topotecan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Advanced Cancer
×
Coping Skills
×
Clear all
NCT01444157
2014-07-18
FamCope
Bispebjerg Hospital
Phase 3
Completed
700 enrolled